Elisabeth von der Lohe, MD
Professor of Clinical Medicine
Krannert Institute of Cardiology, Room E 400 1801 N. Senate Blvd., Suite E400
Indianapolis, IN 46202-1228
Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention.
Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.
Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel response.
Cardiac events after non-cardiac surgery in patients with previous coronary intervention in the drug-eluting stent era.
American Board of Internal Medicine - Interventional Cardiology